AI tool validation for lung nodules found on CT scans
Part of Cancer, Lungs & breathing clinical trials.
This study checks if artificial intelligence (AI) can accurately read CT scans of lung nodules (spots on the lung) to tell if they are cancer. Your participation helps improve diagnosis and may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a lung nodule (a spot on your lung) seen on a CT scan, and it must be no larger than 3 cm (about 1.2 inches).
- You have had a biopsy or surgery to determine if the nodule is cancer, and the results are clear.
- The CT scan and the biopsy or surgery must be within 6 months of each other.
- Your CT images must be complete and of good quality, with no missing parts or severe blurring.
- You have not had chemotherapy, radiation, or targeted therapy for this nodule before the biopsy or surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to help doctors analyze lung nodules seen on CT scans, with the goal of improving diagnosis and follow-up. It may help people who have a lung nodule that needs monitoring or clarification.
This study tests whether an AI-based digital tool can help manage follow-up care for people with high-risk lung nodules (spots on the lung). It aims to improve monitoring and early detection of lung cancer.
This study uses artificial intelligence to analyze CT scans of lung nodules that look like ground glass, which may be early signs of cancer. The goal is to predict how these nodules will grow over time, helping doctors decide whether to monitor or treat them.
This study collects information from your chest CT scans and medical history to build an artificial intelligence model of how your lungs work. This 'digital twin' may help doctors better understand and predict lung health in the future.
This study tests whether an artificial intelligence (AI) tool can help doctors manage lung nodules found on low-dose CT scans. The goal is to improve follow-up care and decisions, potentially helping to catch problems earlier while avoiding unnecessary procedures.
This study tests whether Optellum’s AI prediction tool can better identify which lung nodules found on CT scans are more likely to be cancer. You may be asked to provide specific types of CT images so the tool can be evaluated.
Hear when a new Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.